Drug intelligence / Profile preview

pazufloxacin

Development stage
Phase 3
Lead developer
Fujifilm
Modality
Small Molecules
Administration
Intravenous, Otic
01

Overview

Pazufloxacin is a synthetic broad-spectrum fluoroquinolone antibiotic effective against a wide range of gram-positive and gram-negative bacteria, including drug-resistant and anaerobic strains. It is primarily used to treat urinary tract infections, respiratory tract infections (such as lung abscess and pneumonia), abdominal infections (including peritonitis, liver abscess, gallbladder infection), uterine infection (endometritis), and secondary infections following injuries or surgery. The drug acts by inhibiting bacterial DNA synthesis through dual inhibition of DNA gyrase and topoisomerase IV enzymes. This multimodal mechanism disrupts essential processes such as DNA polymerization, supercoiling, and chromosome fragmentation in bacteria. Its unique structure confers potent antibacterial activity with a low potential for resistance development[4][5][8]. Pazufloxacin is administered intravenously.

Brand names
PazucrossPazucrosPazuflo
Other names
pazufloxacin mesylate
02

Targets

DNA gyraseTopo IV (Bacterial Topoisomerase IV)

Beyond the preview

Go deeper on pazufloxacin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on pazufloxacin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call